Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2023-11-20 00:00:00 ET · period of report 2023-11-16 · accession 0001209191-23-056023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-20 | 2023-11-16 | IRWD | Emany Sravan Kumar | SVP, CFO | F - Tax | $9.44 | -6,661 | 182.1K | -4% | -$62.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-16 | F | D | 6,661 | $9.44 | 182,069 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |